David Tyronne Howton, Jr
2018
Compensation breakdown
| Non-Equity Incentive Plan | $265,628 |
|---|---|
| Option Awards | $2,412,445 |
| Salary | $438,185 |
| Other | $13,118 |
| Total | $3,129,375 |
Howton received $2.4M in option awards, accounting for 77% of the total pay in 2018.
Howton also received $265.6K in non-equity incentive plan, $438.2K in salary and $13.1K in other compensation.
Rankings
In 2018, David Tyronne Howton, Jr's compensation ranked 3,693rd out of 14,244 executives tracked by ExecPay. In other words, Howton earned more than 74.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,693 out of 14,244 | 74th |
Division Manufacturing | 1,370 out of 5,758 | 76th |
Major group Chemicals And Allied Products | 484 out of 2,119 | 77th |
Industry group Drugs | 403 out of 1,808 | 78th |
Industry Pharmaceutical Preparations | 311 out of 1,382 | 78th |
Pay ratio
| David Tyronne Howton, Jr's Pay | $3,129,375 |
|---|---|
| Median Employee's Pay | $329,229 |
| Pay Ratio | 10to 1 |
In 2018, the annual total compensation of David Tyronne Howton, Jr was $3,129,375.
The annual total compensation of the median employee at Sarepta Therapeutics was $329,229.
The ratio of David Tyronne Howton, Jr's pay to the pay of median employee was therefore 10 to one.
Howton's colleagues
We found four more compensation records of executives who worked with David Tyronne Howton, Jr at Sarepta Therapeutics in 2018.